GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (NSE:MANGALAM) » Definitions » Other Long-Term Liabilities

Mangalam Drugs & Organics (NSE:MANGALAM) Other Long-Term Liabilities : ₹141 Mil (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Other Long-Term Liabilities?

Mangalam Drugs & Organics's other long-term liabilities for the quarter that ended in Mar. 2025 was ₹141 Mil.

Mangalam Drugs & Organics's quarterly other long-term liabilities declined from Sep. 2024 (₹115 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹141 Mil).

Mangalam Drugs & Organics's annual other long-term liabilities increased from Mar. 2023 (₹145 Mil) to Mar. 2024 (₹154 Mil) but then declined from Mar. 2024 (₹154 Mil) to Mar. 2025 (₹141 Mil).

Mangalam Drugs & Organics Other Long-Term Liabilities Historical Data

The historical data trend for Mangalam Drugs & Organics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Other Long-Term Liabilities Chart

Mangalam Drugs & Organics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.79 134.95 145.16 153.58 140.95

Mangalam Drugs & Organics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 153.58 - 114.76 - 140.95

Mangalam Drugs & Organics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Mangalam Drugs & Organics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (NSE:MANGALAM) » Definitions » Other Long-Term Liabilities
Comparable Companies
BOM:524202 BOM:524661 NSE:PAR NSE:ZENITHDRUG NSE:SOTAC BOM:531592 BOM:537536 BOM:506128 BOM:524828 NSE:MADHAVBAUG ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
532637:India
Address
P. D'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001
Website
https://www.mangalamdrugs.com
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines